Nagham Nafiz Hendi

Dr. Nagham Nafiz Hendi

Faculty of pharmacy, Applied Science University, Amman, Al ‘Āşimah, Jordan
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2021 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
NHNagham Nafiz Hendi
Nagham Nafiz Hendi
NENoha Elsakrmy
Noha Elsakrmy
DRDindial Ramotar
Dindial Ramotar

Verified
Journal Article
Open access
PDF file
NHNagham Nafiz Hendi
Nagham Nafiz Hendi
JAJamil Alenbawi
Jamil Alenbawi
Georges NemerGeorges Nemer
Georges Nemer
The exponential expansion of genomic data coupled with the lack of appropriate clinical categorization of the variants is posing a major challenge to conventional medications for many common and rare diseases. To narrow this gap and achieve the goals of personalized medicine, a collaborative effort should be made to characterize the genomic variants functionally and clinically with a massive global genomic sequencing of “healthy” subjects from several ethnicities. Familial-based clustered diseases with homogenous genetic backgrounds are amongst the most beneficial tools to help address this challenge. This review will discuss the diagnosis, management, and clinical monitoring of familial hypercholesterolemia patients from a wide angle to cover both the genetic mutations underlying the phenotype, and the pharmacogenomic traits unveiled by the conventional and novel therapeutic approaches. Achieving a drug-related interactive genomic map will potentially benefit populations at risk across the globe who suffer from dyslipidemia.

1 June 2023 in Epigenomics
Verified
Journal Article
Closed access
NHNagham Nafiz Hendi
Nagham Nafiz Hendi
Georges NemerGeorges Nemer
Georges Nemer
Tweetable abstract Epigenetic insights into vitamin D deficiency, a global health concern, are described here. This editorial illuminates the role of epigenetic mechanisms in understanding the mole...

1 August 2024 in Human Genomics
Verified
Journal Article
Open access
PDF file
JAJamil Alenbawi
Jamil Alenbawi
YAYasser A. Al-Sarraj
Yasser A. Al-Sarraj
UUUmm-Kulthum I. Umlai
Umm-Kulthum I. Umlai
AKAyat Kadhi
Ayat Kadhi
NHNagham Nafiz Hendi
Nagham Nafiz Hendi
OAOmar M.E. Albagha
Omar M.E. Albagha
Sitosterolemia is a rare inherited disorder caused by mutations in the ABCG5/ABCG8 genes. These genes encode proteins involved in the transport of plant sterols. Mutations in these genes lead to decreased excretion of phytosterols, which can accumulate in the body and lead to a variety of health problems, including premature coronary artery disease. We conducted the first genome-wide association study (GWAS) in the Middle East/North Africa population to identify genetic determinants of plant sterol levels in Qatari people. GWAS was performed on serum levels of β-sitosterol and campesterol using the Metabolon platform from Qatar Biobank (QBB) and genome sequence data provided by Qatar Genome Program. A trans-ancestry meta-analysis of data from our Qatari cohort with summary statistics from a previously published large cohort (9758 subjects) of European ancestry was conducted. Using conditional analysis, we identified two independent single nucleotide polymorphisms associated with β-sitosterol (rs145164937 and rs4299376), and two others with campesterol (rs7598542 and rs75901165) in the Qatari population in addition to previously reported variants. All of them map to the ABCG5/8 locus except rs75901165 which is located within the Intraflagellar Transport 43 (IFT43) gene. The meta-analysis replicated most of the reported variants, and our study provided significant support for the association of variants in SCARB1 and ABO with sitosterolemia. Evaluation of a polygenic risk score devised from European GWAS data showed moderate performance when applied to QBB (adjusted-R2 = 0.082). These findings provide new insights into the genetic architecture of phytosterol metabolism while showing the importance including under-represented populations in future GWAS studies.

25 March 2018 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
NHNagham Nafiz Hendi
Nagham Nafiz Hendi
MSMohammad I Saleh
Mohammad I Saleh

29 September 2023 in Frontiers in Nutrition
Verified
Journal Article
Open access
NHNagham Nafiz Hendi
Nagham Nafiz Hendi
YAYasser Al-Sarraj
Yasser Al-Sarraj
UUUmm-Kulthum Ismail Umlai
Umm-Kulthum Ismail Umlai
KSKarsten Suhre
Karsten Suhre
Georges NemerGeorges Nemer
Georges Nemer
OAOmar M.E. Albagha
Omar M.E. Albagha
Introduction: Epidemiological studies have consistently revealed that Vitamin D deficiency is most prevalent in Middle Eastern countries. However, research on the impact of genetic loci and polygenic models related to Vitamin D has primarily focused on European populations.Methods: We conducted the first genome-wide association study to identify genetic determinants of Vitamin D levels in Middle Easterners using a whole genome sequencing approach in 6,047 subjects from the Qatar Biobank (QBB) project. We performed a GWAS meta-analysis, combining the QBB cohort with recent European GWAS data from the UK Biobank (involving 345,923 individuals). Additionally, we evaluated the performance of European-derived polygenic risk scores using UK Biobank data in the QBB cohort.Results: Our study identified an association between a variant in a known locus for the group-specific component gene (GC), specifically rs2298850 (p-value = 1.71 × 10−08, Beta = −0.1285), and Vitamin D levels. Furthermore, our GWAS meta-analysis identified two novel variants at a known locus on chromosome 11, rs67609747 and rs1945603, that reached the GWAS significance threshold. Notably, we observed a moderately high heritability of Vitamin D, estimated at 18%, compared to Europeans. Despite the lower predictive performance of Vitamin D levels in Qataris compared to Europeans, the European-derived polygenic risk scores exhibited significant links to Vitamin D deficiency risk within the QBB cohort.Conclusion: This novel study reveals the genetic architecture contributing to Vitamin D deficiency in the Qatari population, emphasizing the genetic heterogeneity across different populations.